HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siong Meng Lim Selected Research

lissamine rhodamine B (sulforhodamine B)

1/2021High-performance thin layer chromatography-based phytochemical and bioactivity characterisation of anticancer endophytic fungal extracts derived from marine plants.
1/2020Synthesis, Characterization, Antimicrobial and Anticancer Studies of Metal Complexes of 2-methoxy-4-((3-methylpyridin-2-ylimino)methyl)phenol.
12/2019Synthesis, molecular modelling and biological significance of N-(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents.
12/20194-(4-Bromophenyl)-thiazol-2-amine derivatives: synthesis, biological activity and molecular docking study with ADME profile.
12/20194-(2-(1H-Benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamides: design, synthesis and biological evaluation.
12/2019In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents.
1/2019Design, Synthesis and Therapeutic Potential of Some 6, 6'-(1,4- phenylene)bis(4-(4-bromophenyl)pyrimidin-2-amine)analogues.
12/2018Design, synthesis and therapeutic potential of 3-(2-(1H-benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamide analogues.
12/2018Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2H-chromen-2-one derivatives.
9/2018Design, synthesis and biological potential of heterocyclic benzoxazole scaffolds as promising antimicrobial and anticancer agents.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siong Meng Lim Research Topics

Disease

18Neoplasms (Cancer)
01/2021 - 05/2012
12Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2017
7Neuroinflammatory Diseases
10/2022 - 06/2015
4Alzheimer Disease (Alzheimer's Disease)
10/2022 - 05/2017
4Breast Neoplasms (Breast Cancer)
12/2018 - 09/2013
4Inflammation (Inflammations)
11/2017 - 06/2015
2Parkinson Disease (Parkinson's Disease)
12/2021 - 10/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 06/2015
2Adenocarcinoma
12/2019 - 12/2019
2Infections
01/2019 - 12/2018
1Cognitive Dysfunction
10/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Memory Disorders (Memory Loss)
12/2021
1Neuroblastoma
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Type 2 Diabetes Mellitus (MODY)
11/2017
1Allergic Rhinitis
07/2017
1Rhinitis
07/2017
1Insulin Resistance
08/2016
1Pain (Aches)
01/2016
1Low Back Pain (Lumbago)
01/2016
1Back Pain (Backache)
01/2016
1Necrosis
06/2015
1Neoplasm Metastasis (Metastasis)
09/2013

Drug/Important Bio-Agent (IBA)

14lissamine rhodamine B (sulforhodamine B)IBA
01/2021 - 08/2017
10Pharmaceutical PreparationsIBA
01/2020 - 08/2017
7Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 08/2017
3Biomarkers (Surrogate Marker)IBA
10/2022 - 10/2017
3Malondialdehyde (Propanedial)IBA
12/2021 - 08/2016
3LipopolysaccharidesIBA
01/2021 - 06/2015
3Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 01/2016
3CytokinesIBA
05/2017 - 09/2013
3Interleukin-6 (Interleukin 6)IBA
08/2016 - 06/2015
2Proteins (Proteins, Gene)FDA Link
10/2022 - 10/2018
2Cholinergic Agents (Cholinergics)IBA
12/2021 - 07/2017
2Amyloid (Amyloid Fibrils)IBA
12/2021 - 07/2017
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 06/2015
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2016
2Anti-Infective Agents (Microbicides)IBA
12/2018 - 08/2017
2Biological ProductsIBA
06/2018 - 08/2017
2Fluconazole (Zonal)FDA LinkGeneric
06/2018 - 08/2017
2Cefadroxil (Duricef)FDA LinkGeneric
06/2018 - 08/2017
2Neuroprotective AgentsIBA
11/2017 - 06/2015
2Interleukin-13IBA
07/2017 - 05/2017
2Substance PIBA
07/2017 - 01/2016
1Fibrinogen (Factor I)FDA Link
10/2022
1Protein Isoforms (Isoforms)IBA
10/2022
1HDL CholesterolIBA
01/2022
1EnzymesIBA
01/2022
1LipidsIBA
01/2022
1AcetylcholinesteraseIBA
12/2021
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2021
1carbazoleIBA
12/2021
1AlkaloidsIBA
12/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
12/2021
1Glutathione (Reduced Glutathione)IBA
12/2021
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2021
1mahanimbineIBA
12/2021
1Coconut OilIBA
01/2021
1InterferonsIBA
01/2021
1AntioxidantsIBA
01/2021
1CopperIBA
01/2020
1Amyloid beta-PeptidesIBA
01/2020
1benzimidazoleIBA
12/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1pyrimidineIBA
01/2019
1TamoxifenFDA LinkGeneric
12/2018
1Schiff Bases (Schiff Base)IBA
11/2018
1Coordination ComplexesIBA
11/2018
1GTP Phosphohydrolases (GTPases)IBA
10/2018
1compound 18IBA
10/2018
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
11/2017
1NAD (NADH)IBA
10/2017
1NeurotoxinsIBA
10/2017
1ciproxifanIBA
07/2017
1InterleukinsIBA
07/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017
1C-Reactive ProteinIBA
08/2016
1Insulin (Novolin)FDA Link
08/2016
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2016
1Cell Adhesion MoleculesIBA
01/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1benzamideIBA
01/2016
1Monocyte Chemoattractant ProteinsIBA
09/2013
1desmethyl-lasiodiplodinIBA
09/2013
1Cytotoxins (Cytolysins)IBA
05/2012

Therapy/Procedure

1Complementary Therapies (Alternative Medicine)
12/2021
1Massage (Zone Therapy)
01/2016
1Physical Therapy Modalities (Physical Therapy Technique)
01/2016